Jayme Mendal - Nov 27, 2019 Form 4 Insider Report for EverQuote, Inc. (EVER)

Role
CEO and President, Director
Signature
/s/ John Wagner, as attorney-in-fact for Jayme Mendal
Stock symbol
EVER
Transactions as of
Nov 27, 2019
Transactions value $
$111,360
Form type
4
Date filed
4/5/2023, 09:42 PM
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVER Class A Common Stock Options Exercise $111K +16K +7.2% $6.96 238K Nov 27, 2019 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVER Employee Stock Option (right to buy) Options Exercise $0 -16K -6% $0.00 251K Nov 27, 2019 Class A Common Stock 16K $6.96 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person's title changed from Chief Operating Officer to CEO and President in November 2020. The Reporting Person was also elected as a director in November 2020.
F2 The Reporting Person inadvertently failed to report the acquisition of these shares of Class A Common Stock, and therefore, the total amount of securities beneficially owned by the Reporting Person and reported in column 5 of Table I was understated by the amount of these shares in each of the Forms 4 filed after November 27, 2019 and before April 5, 2023.
F3 The amount of securities beneficially owned that is reported on this line is as of November 27, 2019.
F4 This option, representing a right to purchase 266,880 shares, was granted on October 18, 2017. The shares underlying the option vested on various dates commencing on September 30, 2018.
F5 Due to the Reporting Person's inadvertent failure to report the exercise of the Employee Stock Option as to 16,000 shares of Class A Common Stock, the number of derivative securities beneficially owned by the Reporting Person following the reported transaction and reported in column 9 of Table II was overstated by this same amount for the Form 4s filed on November 5, 2020 and December 4, 2020, as both Form 4s reported exercises of the Employee Stock Option.